Premium
Estradiol impairs the Th17 immune response against Candida albicans
Author(s) -
Relloso Miguel,
AragonesesFenoll Laura,
Lasarte Sandra,
Bourgeois Christelle,
Romera Gema,
Kuchler Karl,
Corbí Angel L.,
MuñozFernández M. Angeles,
Nombela César,
RodríguezFernández José L.,
DiezOrejas Rosalia
Publication year - 2012
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.1110645
Subject(s) - candida albicans , biology , immune system , ex vivo , immunology , systemic candidiasis , pathogen , hormone , in vivo , corpus albicans , immunity , gastrointestinal tract , microbiology and biotechnology , endocrinology , genetics , biochemistry
In vivo and ex vivo E2‐treated DCs have diminished ability to trigger the Th17 immune response against C. albicans antigens.